Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes, Journal of Biomedical Science

Background Osteoarthritis (OA) is characterized by the degradation of articular cartilage, marked by the breakdown of matrix proteins. Studies demonstrated the involvement of chemokines in this process, and some may potentially serve as diagnostic markers and therapeutic targets; however, the underlying signal transductions are not well understood. Methods We investigated the effects of the CC chemokine eotaxin-1 (CCL11) on the matrix metalloproteinase (MMP) expression and secretion in the human chondrocyte cell line SW1353 and primary chondrocytes. Results Eotaxin-1 significantly induced MMP-3 mRNA expression in a dose-dependent manner. Inhibitors of extracellular signal-regulated kinase (ERK) and p38 kinase were able to repress eotaxin-1-induced MMP-3 expression. On the contrary, Rp-adenosine-3',5'-cyclic monophosphorothioate (Rp-cAMPs), a competitive cAMP antagonist for cAMP receptors, and H-89, a protein kinase A (PKA) inhibitor, markedly enhanced eotaxin-1-induced MMP-3 expression. These results suggest that MMP-3 expression is specifically mediated by the G protein-coupled eotaxin-1 receptor activities. Interestingly, little amount of MMP-3 protein was detected in the cell lysates of eotaxin-1-treated SW1353 cells, and most of MMP-3 protein was in the culture media. Furthermore we found that the eotaxin-1-dependent MMP-3 protein secretion was regulated by phospholipase C (PLC)-protein kinase C (PKC) cascade and c-Jun N-terminal kinase (JNK)/mitogen-activated protein (MAP) kinase pathways. These data indicate a specific regulation of MMP-3 secretion also by eotaxin-1 receptor activities. Conclusions Eotaxin-1 not only induces MMP-3 gene expression but also promotes MMP-3 protein secretion through G protein-coupled eotaxin-1 receptor activities. Chemokines, such as eotaxin-1, could be a potential candidate in the diagnosis and treatment of arthritis.

Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes, Journal of Biomedical Science

TGF-β inhibits IL-1β-activated PAR-2 expression through multiple pathways in human primary synovial cells, Journal of Biomedical Science

Hyaluronan regulates PPARγ and inflammatory responses in IL-1β-stimulated human chondrosarcoma cells, a model for osteoarthritis - ScienceDirect

TGF-β inhibits IL-1β-activated PAR-2 expression through multiple pathways in human primary synovial cells, Journal of Biomedical Science

Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease - T.A. Silva, G.P. Garlet, S.Y. Fukada, J.S. Silva, F.Q. Cunha, 2007

Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes, Journal of Biomedical Science

Synovial Fluid Eotaxin-1 Levels May Reflect Disease Progression in Primary Knee Osteoarthritis Among Elderly Han Chinese: A Cross-Sectional Study - Bei Li, Yi-Li Zhang, Shou-Yi Yu, 2019

Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression

Molecules, Free Full-Text

Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes - ScienceDirect

New findings in osteoarthritis pathogenesis: therapeutic implications - Lia Pulsatelli, Olga Addimanda, Veronica Brusi, Branka Pavloska, Riccardo Meliconi, 2013

Chemokines and chemokine receptors in leukocyte trafficking American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Response of Endothelial Cells to Gelatin-Based Hydrogels

Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness - ScienceDirect

Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1